From: ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
RM11A+Dox
RM11A+Dox/ErbB2
Number of mice injected
38
31
Number of palpable tumors
29
42
Number of tumors per mouse
0.76
1.35
Average tumor latency (d)
47.9
22.1a